Table 5.
Results of univariate survival analysis using log rank test for other clinicopathologic parameters.
| OS | DSS | RFS | |
|---|---|---|---|
| Clinical parameters | |||
| Age (continuous) | 0.006 | NS | NS |
| Sex | NS | NS | NS |
| Post-operative radiation therapy | NS | NS | NS |
| Post-operative chemotherapy | 0.019 | 0.048 | 0.004 |
| Characteristics of primary tumors | |||
| AJCC pT stage/tumor size categorical) | NS | 0.008 | 0.003 |
| Tumor size (continuous) | 0.024 | 0.002 | 0.004 |
| Lymphovascular invasion | NS | NS | NS |
| Perineural invasion | <0.001 | 0.029 | 0.033 |
| Margin status | NS | NS | NS |
| Characteristics of nodal metastasis | |||
| AJCC pN stage | <0.002 | 0.001 | 0.004 |
| Size of largest involved lymph node (continuous) | NS | NS | NS |
| Size of largest metastasis continuous) | NS | NS | NS |
| Laterality of positive lymph node | NS | NS | 0.011 |
| Number of positive lymph nodes | <0.001 | 0.002 | 0.012 |
| Rounded/well-circumscribed soft tissue deposit | NS | NS | NS |
| Subgroups of cases with ENE | |||
| Vertical extent of ENE continuous) | NS | 0.049 | NS |
| Horizontal extent of ENE continuous) | NS | NS | NS |
| Size of lymph node with most ENE ((continuous) | NS | NS | 0.034 |
| Size ratio of metastasis/involved lymph node in the lymph node with the most ENE (continuous) | NS | NS | NS |
| Number of positive lymph nodes with ENE | 0.003 | 0.020 | NS |
| Tissue involved by ENE | 0.019 | 0.002 | 0.040 |
| Desmoplastic reaction in ENE | NS | NS | NS |
| Irregular soft tissue deposit | <0.001 | <0.001 | <0.001 |
NS non-significant.
Values are P values obtained using log rank test for categorical variables and cox proportional hazards model for continuous variables.